|
6051 |
Prostatakrebs: Therapie zu wenig an Lebenserwartung orientiert
Enthalten in Im Focus Onkologie Bd. 28, 7.2.2025, Nr. 1, date:2.2025: 16-17
|
|
|
|
6052 |
Prostatakrebs: Zu viel Screening führt zu Übertherapie
Enthalten in Uro-News Bd. 28, 4.12.2024, Nr. 12, date:12.2024: 47
|
|
|
|
6053 |
Prostatatumoren bevorzugen zwei Evolutionspfade
Enthalten in Uro-News Bd. 28, 5.6.2024, Nr. 6, date:6.2024: 47
|
|
|
|
6054 |
Prostatatumoren mit zwei Evolutionspfaden
Enthalten in Uro-News Bd. 28, 10.7.2024, Nr. 7-8, date:7.2024: 37
|
|
|
|
6055 |
Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity
Enthalten in Nature genetics Bd. 50, 22.12.2017, Nr. 1, date:1.2018: 26-41
|
|
|
|
6056 |
Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution
Enthalten in Nature genetics Bd. 51, 18.2.2019, Nr. 3, date:3.2019: 452-469
|
|
|
|
6057 |
Proteomic profiling in cerebral amyloid angiopathy reveals an overlap with CADASIL highlighting accumulation of HTRA1 and its substrates
Enthalten in Acta Neuropathologica Communications Bd. 10, 24.1.2022, Nr. 1, date:12.2022: 1-15
|
|
|
|
6058 |
Proteomics based selection achieves complete response to HER2 therapy in HER2 IHC 0 breast cancer
Enthalten in npj precision oncology Bd. 8, 14.9.2024, Nr. 1, date:12.2024: 1-7
|
|
|
|
6059 |
Proteomics for blood biomarker exploration of severe mental illness: pitfalls of the past and potential for the future
Enthalten in Translational Psychiatry Bd. 8, 16.8.2018, Nr. 1, date:12.2018: 1-15
|
|
|
|
6060 |
Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease – a randomized, open-label, multicenter phase II trial
Enthalten in BMC cancer Bd. 22, 24.9.2022, Nr. 1, date:12.2022: 1-9
|
|
Administration
